…
AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. The company operates through four segments: Direct Sales, Pharmacy, Hotel, and Manufacture and Sale. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat's milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. The company also engages in hotel business. It provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. The company sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. The company is based in Chengdu, China.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -2.77M | -2.07M | -6.37M | 0.01M | 1.36M |
| Net income | -2.77M | -2.09M | -6.37M | -0.27M | 1.02M |
| Selling general administrative | 3.20M | 3.16M | 2.55M | 1.88M | 1.42M |
| Gross profit | 0.61M | 0.66M | 2.71M | 3.07M | 2.23M |
| Reconciled depreciation | 0.32M | 0.41M | 0.19M | 0.10M | 0.04M |
| Ebit | - | - | -6.37M | 0.00M | 0.79M |
| Ebitda | - | - | -2.38M | 0.07M | 0.84M |
| Non operating income net other | - | - | -3.80M | 0.03M | - |
| Operating income | -2.59M | -2.50M | -2.57M | -0.03M | 0.79M |
| Other operating expenses | - | - | 2.72M | 1.22M | - |
| Interest expense | - | - | 0.00M | 0.00M | 0.00M |
| Tax provision | 0.00M | 0.02M | 0.00M | 0.27M | 0.34M |
| Interest income | - | 0.00M | 0.00M | 0.00M | 0.54M |
| Net interest income | -0.08M | 0.00M | 0.00M | 0.00M | 0.54M |
| Income tax expense | - | - | 0.00M | 0.27M | 0.34M |
| Total revenue | 3.82M | 4.09M | 2.71M | 3.07M | 2.45M |
| Total operating expenses | 6.41M | 6.59M | 5.28M | 3.09M | 1.66M |
| Cost of revenue | 3.21M | 3.43M | 1.10M | 0.54M | 0.22M |
| Total other income expense net | -0.10M | 0.43M | -3.80M | 0.03M | 0.03M |
| Net income from continuing ops | -2.77M | -2.09M | -6.37M | -0.27M | 1.02M |
| Net income applicable to common shares | - | - | -6.37M | -0.27M | 1.02M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 4.41M | 4.84M | 5.05M | 11.66M | 8.09M |
| Intangible assets | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Other current assets | - | - | 0.15M | 0.14M | 0.18M |
| Total liab | 8.69M | 6.75M | 5.52M | 5.59M | 1.20M |
| Total stockholder equity | -4.28M | -1.91M | -0.47M | 6.07M | 6.89M |
| Other current liab | - | - | 2.14M | 1.02M | 0.53M |
| Common stock | - | - | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -19.99M | -17.22M | -15.25M | -8.88M | -4.81M |
| Good will | - | 0.00M | 0.00M | - | - |
| Other assets | - | - | - | 0.11M | - |
| Cash | 0.06M | 0.44M | 0.51M | 8.60M | 7.68M |
| Total current liabilities | 7.47M | 5.96M | 5.32M | 4.45M | 1.17M |
| Short term debt | - | - | 0.09M | 0.09M | - |
| Short long term debt | - | 0.08M | 0.09M | 0.09M | - |
| Other stockholder equity | - | - | 0.32M | 0.86M | 0.59M |
| Property plant equipment | - | - | 1.97M | 0.29M | 0.17M |
| Total current assets | 1.45M | 1.50M | 1.98M | 9.21M | 7.93M |
| Net tangible assets | - | - | -0.47M | 6.07M | 6.89M |
| Net receivables | 0.67M | 0.25M | 0.65M | 0.06M | 0.00M |
| Inventory | 0.50M | 0.44M | 0.67M | 0.40M | 0.05M |
| Accounts payable | 0.86M | 0.48M | 3.10M | 3.34M | 0.04M |
| Common stock total equity | - | - | 0.00M | 0.00M | - |
| Retained earnings total equity | - | - | -15.25M | -8.88M | - |
| Non currrent assets other | - | - | 1.09M | 2.14M | - |
| Non current assets total | 2.95M | 3.34M | 0.02M | 0.02M | 0.17M |
| Capital lease obligations | 1.32M | 1.65M | 1.08M | 1.99M | 0.10M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | -0.20M | -0.30M | -3.52M | -4.43M | 4.09M |
| Change to liabilities | - | - | 0.18M | -0.23M | 0.00M |
| Total cashflows from investing activities | - | - | -3.52M | -4.43M | 4.09M |
| Net borrowings | - | - | -2.39M | 0.84M | 1.55M |
| Total cash from financing activities | 1.43M | 1.56M | -2.39M | 5.22M | 1.55M |
| Change to operating activities | - | - | - | -0.52M | -0.30M |
| Net income | -2.77M | -2.09M | -6.37M | -0.27M | 1.02M |
| Change in cash | -0.40M | -0.15M | -7.54M | 0.73M | 7.67M |
| Begin period cash flow | 0.47M | 0.62M | 8.60M | 7.68M | 0.01M |
| End period cash flow | 0.06M | 0.47M | 0.62M | 8.60M | 7.68M |
| Total cash from operating activities | -1.63M | -1.39M | -1.62M | -0.06M | 1.61M |
| Issuance of capital stock | - | - | - | 4.39M | - |
| Depreciation | 0.32M | 0.41M | 0.19M | 0.10M | 0.04M |
| Other cashflows from investing activities | - | - | -3.37M | -4.43M | 4.09M |
| Change to inventory | -0.09M | 0.04M | 0.15M | 0.07M | 0.14M |
| Change to account receivables | -0.21M | 0.48M | -0.43M | 0.01M | 0.01M |
| Other cashflows from financing activities | - | - | - | 4.39M | - |
| Change to netincome | - | - | 4.30M | 0.35M | 0.54M |
| Capital expenditures | 0.24M | 0.30M | 0.16M | 0.00M | 0.00M |
| Change receivables | - | - | -0.43M | 0.01M | - |
| Cash flows other operating | - | - | 0.35M | -0.09M | - |
| Cash and cash equivalents changes | - | - | -7.54M | 0.73M | - |
| Change in working capital | 0.35M | 0.27M | 0.13M | -0.18M | 0.17M |
| Stock based compensation | 0.30M | 0.37M | 0.37M | 0.37M | 0.37M |
| Other non cash items | 0.11M | -0.33M | 0.13M | -0.06M | - |
| Free cash flow | -1.87M | -1.69M | -1.78M | -0.06M | 1.61M |
Sector: Consumer Defensive Industry: Food Distribution
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SYY Sysco Corporation |
1.02 1.32% |
78.17 | 22.81 | 16.47 | 0.45 | 15.01 | 0.63 | 12.91 |
| JRONY Jeronimo Martins SGPS SA ADR |
0.05 0.12% |
42.19 | 19.98 | 23.09 | 0.54 | 5.70 | 0.62 | 8.86 |
| JRONF Jerónimo Martins SGPS S.A |
- -% |
22.27 | 20.43 | 16.39 | 0.40 | 3.86 | 0.39 | 5.87 |
| USFD US Foods Holding Corp |
0.55 0.51% |
107.37 | 25.21 | 13.79 | 0.31 | 2.33 | 0.44 | 11.80 |
AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. The company operates through four segments: Direct Sales, Pharmacy, Hotel, and Manufacture and Sale. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat's milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. The company also engages in hotel business. It provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. The company sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. The company is based in Chengdu, China.
Hongxing Intl. Business Bldg 2, Chengdu, China, 610021
86 31 3673 2526
120
| Name | Title | Year Born |
|---|---|---|
| Mr. Quanzhong Lin | Chairman, Pres & CEO | 1979 |
| Ms. Tianfeng Li | Chief Financial Officer | 1987 |
| Mr. Quanzhong Lin | Secretary, President, CEO & Chairman | 1979 |
| Ms. Tianfeng Li | CFO & Treasurer | 1984 |
| Mr. Xiaowen Zheng | Chief Financial Officer | 1986 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.